Literature DB >> 26994616

Effects of prolonged fasting on fatigue and quality of life in patients with multiple sclerosis.

Masoud Etemadifar1,2, Farnaz Sayahi2, Raed Alroughani3, Nafiseh Toghianifar1,2, Mojtaba Akbari4, Zahra Nasr5,6.   

Abstract

Fasting is one of the recommended worships of several great religions in the world. During the month of Ramadan, circadian rhythm and pattern of eating changes result in physiological, biochemical and hormonal changes in the body. Many Muslims with medical conditions ask their physicians about the feasibility and safety of fasting during Ramadan. In this study, we aim to assess the effect of Ramadan fasting on the quality of life and fatigue in multiple sclerosis (MS) patients. Relapsing-remitting MS (RRMS) patients according to McDonald's criteria who had mild disability (EDSS score ≤3) were included in this study. Fatigue and quality of life were were assessed using the validated Persian versions of modified fatigue impact scale (MFIS) and multiple sclerosis quality of life-54 (MSQOL-54) questionnaires, respectively. 218 patients (150 females and 68 males) were enrolled in our study. There was no statistically significant difference between the mean total score of MSIF before and after fasting (25.50 ± 13.81 versus 26.94 ± 16.65; p = 0.58). The mean physical health and mental health composites of quality of life increased significantly after fasting (p = 0.008 and p = 0.003 respectively). Despite the observed lack of favorable effects on fatigue, our results showed increased quality of life of MS patients once Ramadan has ended. Whether this is specifically related to Ramadan-related fasting deserves further testing in appropriately designed larger prospective clinical studies.

Entities:  

Keywords:  Fasting; Fatigue; Islam; Multiple sclerosis; Quality of life

Mesh:

Year:  2016        PMID: 26994616     DOI: 10.1007/s10072-016-2518-9

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  22 in total

Review 1.  Caloric restriction and intermittent fasting: two potential diets for successful brain aging.

Authors:  Bronwen Martin; Mark P Mattson; Stuart Maudsley
Journal:  Ageing Res Rev       Date:  2006-08-08       Impact factor: 10.895

Review 2.  Epidemiology of multiple sclerosis in Iran: a systematic review.

Authors:  Masoud Etemadifar; Sepideh Sajjadi; Zahra Nasr; Toktam Sadat Firoozeei; Seyed-Hossein Abtahi; Mojtaba Akbari; Mahboobeh Fereidan-Esfahani
Journal:  Eur Neurol       Date:  2013-11-02       Impact factor: 1.710

3.  Ramadan fasting ameliorates arterial pulse pressure and lipid profile, and alleviates oxidative stress in hypertensive patients.

Authors:  Ahmad I M Al-Shafei
Journal:  Blood Press       Date:  2013-09-23       Impact factor: 2.835

4.  Increased fat oxidation during Ramadan fasting in healthy women: an adaptative mechanism for body-weight maintenance.

Authors:  J el Ati; C Beji; J Danguir
Journal:  Am J Clin Nutr       Date:  1995-08       Impact factor: 7.045

5.  Quality of life and social support in patients with multiple sclerosis.

Authors:  Krystyna Jaracz; Mikołaj Pawlak; Krystyna Górna; Błażeja Kołcz; Dorota Wołoszyn; Wojciech Kozubski
Journal:  Neurol Neurochir Pol       Date:  2010 Jul-Aug       Impact factor: 1.621

6.  Validity and reliability of the Persian version of the multiple sclerosis quality of life questionnaire.

Authors:  H Ghaem; A Borhani Haghighi; P Jafari; A R Nikseresht
Journal:  Neurol India       Date:  2007 Oct-Dec       Impact factor: 2.117

Review 7.  Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria".

Authors:  Chris H Polman; Stephen C Reingold; Gilles Edan; Massimo Filippi; Hans-Peter Hartung; Ludwig Kappos; Fred D Lublin; Luanne M Metz; Henry F McFarland; Paul W O'Connor; Magnhild Sandberg-Wollheim; Alan J Thompson; Brian G Weinshenker; Jerry S Wolinsky
Journal:  Ann Neurol       Date:  2005-12       Impact factor: 10.422

8.  The effect of ramadan fasting on biochemical and performance parameters in collegiate wrestlers.

Authors:  Bahman Mirzaei; Farhad Rahmani-Nia; Mahdi Ghahremani Moghadam; Seyed Javad Ziyaolhagh; Abolfazl Rezaei
Journal:  Iran J Basic Med Sci       Date:  2012-11       Impact factor: 2.699

Review 9.  Quality of life in multiple sclerosis.

Authors:  Józef A Opara; Krystyna Jaracz; Waldemar Brola
Journal:  J Med Life       Date:  2010 Oct-Dec

10.  Religious cognitive-emotional therapy: a new form of psychotherapy.

Authors:  Ali Reza Rajaei
Journal:  Iran J Psychiatry       Date:  2010
View more
  6 in total

Review 1.  Ethical conflicts in the treatment of fasting Muslim patients with diabetes during Ramadan.

Authors:  Ilhan Ilkilic; Hakan Ertin
Journal:  Med Health Care Philos       Date:  2017-12

Review 2.  Effect of exercise therapy on quality of life of patients with multiple sclerosis in Iran: a systematic review and meta-analysis.

Authors:  Abolhassan Afkar; Asieh Ashouri; Marjan Rahmani; Abdolhosein Emami Sigaroudi
Journal:  Neurol Sci       Date:  2017-07-07       Impact factor: 3.307

Review 3.  Effects of dietary restriction on gut microbiota and CNS autoimmunity.

Authors:  Claudia Cantoni; Yair Dorsett; Luigi Fontana; Yanjiao Zhou; Laura Piccio
Journal:  Clin Immunol       Date:  2020-08-18       Impact factor: 3.969

Review 4.  Targeting the gut to treat multiple sclerosis.

Authors:  Laura Ghezzi; Claudia Cantoni; Gabriela V Pinget; Yanjiao Zhou; Laura Piccio
Journal:  J Clin Invest       Date:  2021-07-01       Impact factor: 19.456

5.  Integrated Imaginative Distention Therapy to Cope with Fatigue. DIMMI SI Study: The First Randomized Controlled Trial in Multiple Sclerosis.

Authors:  Annalisa Sgoifo; Angelo Bignamini; Loredana La Mantia; Maria G Celani; Piero Parietti; Maria A Ceriani; Maria R Marazzi; Paola Proserpio; Lino Nobili; Alessandra Protti; Elio C Agostoni
Journal:  Neurol Ther       Date:  2017-08-09

6.  Effects of dietary restriction on neuroinflammation in neurodegenerative diseases.

Authors:  Luigi Fontana; Laura Ghezzi; Anne H Cross; Laura Piccio
Journal:  J Exp Med       Date:  2021-02-01       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.